Courier Therapeutics competitorsClear all

Courier Therapeutics's top competitors include Agios Pharmaceuticals, Accent Therapeutics, ABL Bio and Lyell.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Courier Therapeutics
Courier Therapeutics
Courier Therapeutics is a biotechnology company providing a cytotoxic-lymphocyte targeting therapy platform.
Agios Pharmaceuticals
Agios Pharmaceuticals
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
Accent Therapeutics
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company engaged in the development of therapies for cancer.
ABL Bio
ABL Bio
ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease.
Lyell
Lyell
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
Founding Date
Founding Date
2015
Founding Date
2008
Founding Date
2017
Founding Date
2016
Founding Date
2018
Type
Type
Private
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Houston, US HQ
Houston, US
Locations
Cambridge, US HQ
Locations
Lexington, US HQ
Locations
HQ
Locations
South San Francisco, US HQ
Bothell, US
Seattle, US
Employees
Employees
2
Employees
53611% increase
Employees
497% increase
Employees
323% increase
Employees
188
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1.9 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
2.8 b
Twitter followers
Twitter followers
2
Twitter followers
2.2 k
Twitter followers
619
Twitter followers
N/A
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
250011
Alexa Website Rank
391835
Alexa Website Rank
282220
Alexa Website Rank
63208
Alexa Website Rank
500468
Employee Rating
Employee Rating
N/A
Employee Rating
4.2
Employee Rating
5
Employee Rating
3
Employee Rating
4

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 63m (over 1 year ago)
Latest funding round
$ 65m (over 3 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 103m
Total funding raised
$ 90.8m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Agios Pharmaceuticals
HQ
Cambridge, US
Employees
536↑ 11% increase

Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.

View company
Accent Therapeutics
HQ
Lexington, US
Employees
49↑ 7% increase

Accent Therapeutics is a biopharmaceutical company engaged in the development of therapies for cancer.

View company
ABL Bio
HQ
Employees
32↑ 3% increase

ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease.

View company
Lyell
HQ
South San Francisco, US
Employees
188

Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.

View company